<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<bel:document xmlns:bel="http://belframework.org/schema/1.0/xbel" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://belframework.org/schema/1.0/xbel http://resource.belframework.org/belframework/1.0/schema/xbel.xsd">
    <bel:header>
        <bel:name>BEL Framework Three Citation Corpus Document</bel:name>
        <bel:description>3 PubMeds</bel:description>
        <bel:version>1.2</bel:version>
        <bel:copyright>Copyright (c) 2011, Selventa. All Rights Reserved.</bel:copyright>
        <bel:contactInfo>support@belframework.org</bel:contactInfo>
        <bel:authorGroup>
            <bel:author>Selventa</bel:author>
        </bel:authorGroup>
        <bel:licenseGroup>
            <bel:license>Creative Commons Attribution-Non-Commercial-ShareAlike 3.0 Unported License</bel:license>
        </bel:licenseGroup>
    </bel:header>
    <bel:namespaceGroup>
        <bel:namespace bel:resourceLocation="http://resource.belframework.org/belframework/1.0/namespace/selventa-named-rat-protein-families.belns" bel:prefix="PFR" />
        <bel:namespace bel:resourceLocation="http://resource.belframework.org/belframework/1.0/namespace/selventa-named-rat-complexes.belns" bel:prefix="NCR" />
        <bel:namespace bel:resourceLocation="http://resource.belframework.org/belframework/1.0/namespace/selventa-named-mouse-protein-families.belns" bel:prefix="PFM" />
        <bel:namespace bel:resourceLocation="http://resource.belframework.org/belframework/1.0/namespace/selventa-named-mouse-complexes.belns" bel:prefix="NCM" />
        <bel:namespace bel:resourceLocation="http://resource.belframework.org/belframework/1.0/namespace/selventa-named-human-protein-families.belns" bel:prefix="PFH" />
        <bel:namespace bel:resourceLocation="http://resource.belframework.org/belframework/1.0/namespace/selventa-named-human-complexes.belns" bel:prefix="NCH" />
        <bel:namespace bel:resourceLocation="http://resource.belframework.org/belframework/1.0/namespace/rgd-approved-symbols.belns" bel:prefix="RGD" />
        <bel:namespace bel:resourceLocation="http://resource.belframework.org/belframework/1.0/namespace/mgi-approved-symbols.belns" bel:prefix="MGI" />
        <bel:namespace bel:resourceLocation="http://resource.belframework.org/belframework/1.0/namespace/mesh-diseases.belns" bel:prefix="MESHD" />
        <bel:namespace bel:resourceLocation="http://resource.belframework.org/belframework/1.0/namespace/mesh-cellular-locations.belns" bel:prefix="MESHCL" />
        <bel:namespace bel:resourceLocation="http://resource.belframework.org/belframework/1.0/namespace/mesh-biological-processes.belns" bel:prefix="MESHPP" />
        <bel:namespace bel:resourceLocation="http://resource.belframework.org/belframework/1.0/namespace/hgnc-approved-symbols.belns" bel:prefix="HGNC" />
        <bel:namespace bel:resourceLocation="http://resource.belframework.org/belframework/1.0/namespace/go-biological-processes-names.belns" bel:prefix="GO" />
        <bel:namespace bel:resourceLocation="http://resource.belframework.org/belframework/1.0/namespace/entrez-gene-ids-hmr.belns" bel:prefix="EGID" />
        <bel:namespace bel:resourceLocation="http://resource.belframework.org/belframework/1.0/namespace/chebi-names.belns" bel:prefix="CHEBI" />
        <bel:namespace bel:resourceLocation="http://resource.belframework.org/belframework/1.0/namespace/chebi-ids.belns" bel:prefix="CHEBIID" />
        <bel:namespace bel:resourceLocation="http://resource.belframework.org/belframework/1.0/namespace/selventa-legacy-chemical-names.belns" bel:prefix="SCHEM" />
        <bel:namespace bel:resourceLocation="http://resource.belframework.org/belframework/1.0/namespace/swissprot-accession-numbers.belns" bel:prefix="SPAC" />
        <bel:namespace bel:resourceLocation="http://resource.belframework.org/belframework/1.0/namespace/selventa-legacy-diseases.belns" bel:prefix="SDIS" />
    </bel:namespaceGroup>
    <bel:annotationDefinitionGroup>
        <bel:internalAnnotationDefinition bel:id="TextLocation">
            <bel:description>indicates which section of text a statement is derived from</bel:description>
            <bel:usage>indicates which section of text a statement is derived from</bel:usage>
            <bel:listAnnotation>
                <bel:listValue>Abstract</bel:listValue>
                <bel:listValue>Results</bel:listValue>
                <bel:listValue>Legend</bel:listValue>
                <bel:listValue>Review</bel:listValue>
            </bel:listAnnotation>
        </bel:internalAnnotationDefinition>
        <bel:externalAnnotationDefinition bel:id="CellLine" bel:url="http://resource.belframework.org/belframework/1.0/annotation/atcc-cell-line.belanno" />
        <bel:externalAnnotationDefinition bel:id="BodyRegion" bel:url="http://resource.belframework.org/belframework/1.0/annotation/mesh-body-region.belanno" />
        <bel:externalAnnotationDefinition bel:id="CardiovascularSystem" bel:url="http://resource.belframework.org/belframework/1.0/annotation/mesh-cardiovascular-system.belanno" />
        <bel:externalAnnotationDefinition bel:id="CellStructure" bel:url="http://resource.belframework.org/belframework/1.0/annotation/mesh-cell-structure.belanno" />
        <bel:externalAnnotationDefinition bel:id="Cell" bel:url="http://resource.belframework.org/belframework/1.0/annotation/mesh-cell.belanno" />
        <bel:externalAnnotationDefinition bel:id="DigestiveSystem" bel:url="http://resource.belframework.org/belframework/1.0/annotation/mesh-digestive-system.belanno" />
        <bel:externalAnnotationDefinition bel:id="Disease" bel:url="http://resource.belframework.org/belframework/1.0/annotation/mesh-disease.belanno" />
        <bel:externalAnnotationDefinition bel:id="EndocrineSystem" bel:url="http://resource.belframework.org/belframework/1.0/annotation/mesh-endocrine-system.belanno" />
        <bel:externalAnnotationDefinition bel:id="FluidAndSecretion" bel:url="http://resource.belframework.org/belframework/1.0/annotation/mesh-fluid-and-secretion.belanno" />
        <bel:externalAnnotationDefinition bel:id="HemicAndImmuneSystem" bel:url="http://resource.belframework.org/belframework/1.0/annotation/mesh-hemic-and-immune-system.belanno" />
        <bel:externalAnnotationDefinition bel:id="MuskuloskeletalSystem" bel:url="http://resource.belframework.org/belframework/1.0/annotation/mesh-musculoskeletal-system.belanno" />
        <bel:externalAnnotationDefinition bel:id="NervousSystem" bel:url="http://resource.belframework.org/belframework/1.0/annotation/mesh-nervous-system.belanno" />
        <bel:externalAnnotationDefinition bel:id="RespiratorySystem" bel:url="http://resource.belframework.org/belframework/1.0/annotation/mesh-respiratory-system.belanno" />
        <bel:externalAnnotationDefinition bel:id="Tissue" bel:url="http://resource.belframework.org/belframework/1.0/annotation/mesh-tissue.belanno" />
        <bel:externalAnnotationDefinition bel:id="UrogenitalSystem" bel:url="http://resource.belframework.org/belframework/1.0/annotation/mesh-urogenital-system.belanno" />
        <bel:externalAnnotationDefinition bel:id="Species" bel:url="http://resource.belframework.org/belframework/1.0/annotation/species-taxonomy-id.belanno" />
        <bel:externalAnnotationDefinition bel:id="SenseOrgan" bel:url="http://resource.belframework.org/belframework/1.0/annotation/mesh-sense-organ.belanno" />
        <bel:externalAnnotationDefinition bel:id="IntegumentarySystem" bel:url="http://resource.belframework.org/belframework/1.0/annotation/mesh-integumentary-system.belanno" />
    </bel:annotationDefinitionGroup>
    <bel:statementGroup>
        <bel:name>Pubmed 12928037</bel:name>
        <bel:annotationGroup>
            <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
            <bel:citation bel:type="PubMed">
                <bel:reference>12928037</bel:reference>
                <bel:name>Trends in molecular medicine</bel:name>
                <bel:authorGroup>
                    <bel:author>de Nigris F</bel:author>
                    <bel:author>Lerman A</bel:author>
                    <bel:author>Ignarro LJ</bel:author>
                    <bel:author>Williams-Ignarro S</bel:author>
                    <bel:author>Sica V</bel:author>
                    <bel:author>Baker AH</bel:author>
                    <bel:author>Lerman LO</bel:author>
                    <bel:author>Geng YJ</bel:author>
                    <bel:author>Napoli C</bel:author>
                </bel:authorGroup>
            </bel:citation>
        </bel:annotationGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">Atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="CardiovascularSystem">Arteries</bel:annotation>
                <bel:evidence>Oxidation and nitration of macromolecules, such as
proteins, DNA and lipids, are prominent in atherosclerotic
arteries.</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="positiveCorrelation">
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="pathology">
                        <bel:parameter bel:ns="MESHD">Atherosclerosis</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">lipid oxidation</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="positiveCorrelation">
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="pathology">
                        <bel:parameter bel:ns="MESHD">Atherosclerosis</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">protein oxidation</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:annotation bel:refID="CardiovascularSystem">Arteries</bel:annotation>
                <bel:evidence>Arterial cells are
highly susceptible to oxidative stress, which can induce
both necrosis and apoptosis (programmed cell death) [1,2].</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="increases">
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">response to oxidative stress</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">apoptosis</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="increases">
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">response to oxidative stress</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">necrosis</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:evidence>One such risk factor is oxLDL,
which exert pro-apoptotic effects on a variety of cell
lineages, including endothelial cells and VSMCs, both in
cultured cells and in arteries. [19–26]. Increased formation
of oxygen radicals (and other radical species)
facilitates LDL oxidation and influences oxidation-sensitive
mechanisms [15]. It</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="increases">
                <bel:annotationGroup>
                    <bel:annotation bel:refID="Cell">Endothelial Cells</bel:annotation>
                </bel:annotationGroup>
                <bel:subject>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="SCHEM">Oxidized Low Density Lipoprotein</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">apoptosis</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="increases">
                <bel:annotationGroup>
                    <bel:annotation bel:refID="MuskuloskeletalSystem">Muscle, Smooth, Vascular</bel:annotation>
                </bel:annotationGroup>
                <bel:subject>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="SCHEM">Oxidized Low Density Lipoprotein</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">apoptosis</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="increases">
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="CHEBI">oxygen radical</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="SCHEM">Oxidized Low Density Lipoprotein</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:evidence>Not surprisingly, high concentrations of exogenous
reactive oxygen species (ROS), generated by enzymatic
reactions or by radiation, also stimulate the apoptosis of
endothelial cells in vitro [29–31].</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="increases">
                <bel:annotationGroup>
                    <bel:annotation bel:refID="Cell">Endothelial Cells</bel:annotation>
                </bel:annotationGroup>
                <bel:subject>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="CHEBI">reactive oxygen species</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">apoptosis</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:evidence>The peptide hormone angiotensin II and
pro-inflammatory cytokines also trigger the apoptotic
program in endothelial cells [33,34].</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="increases">
                <bel:annotationGroup>
                    <bel:annotation bel:refID="Cell">Endothelial Cells</bel:annotation>
                </bel:annotationGroup>
                <bel:subject>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="CHEBI">angiotensin II</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">apoptosis</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:evidence>Aging, one of the
major predictors for atherosclerotic lesion formation,
increases the sensitivity of endothelial cells to apoptosis
induced by in vitro and in vivo stimuli [35–37].</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="positiveCorrelation">
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">aging</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="pathology">
                        <bel:parameter bel:ns="MESHD">Plaque, Atherosclerotic</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="increases">
                <bel:annotationGroup>
                    <bel:annotation bel:refID="Cell">Endothelial Cells</bel:annotation>
                </bel:annotationGroup>
                <bel:subject>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">aging</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">apoptosis</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:annotation bel:refID="Cell">Endothelial Cells</bel:annotation>
                <bel:evidence>Shear stress
enhances expression of the gene encoding the endothelial
nitric oxide synthase (eNOS) and further stimulates its
enzymatic activity, leading to physiologic low concentrations
of nitric oxide (NO) within endothelial cells
[44–46]. This continuous generation of NO prevents the
apoptosis of endothelial cells, thereby protecting the
endothelial monolayer from injury [47,48].</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="increases">
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">response to fluid shear stress</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="rnaAbundance">
                        <bel:parameter bel:ns="HGNC">NOS3</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="increases">
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">response to fluid shear stress</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="catalyticActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">NOS3</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="catalyticActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">NOS3</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="CHEBI">nitric oxide</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="decreases">
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="CHEBI">nitric oxide</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">apoptosis</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">Atherosclerosis</bel:annotation>
                <bel:evidence>More importantly,
intervention with L-arginine has induced beneficial
effects on atherosclerosis in experimental and human
studies [46,49].</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="decreases">
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="CHEBI">L-arginine</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="pathology">
                        <bel:parameter bel:ns="MESHD">Atherosclerosis</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:annotation bel:refID="Tissue">Endothelium, Vascular</bel:annotation>
                <bel:evidence>OxLDL induces the generation of ROS in different
vascular cell types [15,58], and might also promote a rise
in ROS levels through a decrease in ROS degradation,
because oxLDL induces a reduction in the antioxidant
enzymes Cu/Zn superoxide dismutase [59] and glutathione
peroxidase [60].</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="increases">
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="SCHEM">Oxidized Low Density Lipoprotein</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="CHEBI">reactive oxygen species</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="decreases">
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="SCHEM">Oxidized Low Density Lipoprotein</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">SOD1</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="decreases">
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="SCHEM">Oxidized Low Density Lipoprotein</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="PFH">GPX Family</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:annotation bel:refID="CellLine">U-937</bel:annotation>
                <bel:evidence>For instance,
during 7-ketocholesterol-induced apoptosis of U937 cells,
the cellular antioxidant content falls rapidly [64], but
administration of two potent antioxidants, the aminothiols
glutathione andN-acetylcysteine, can protect themonocytic
cells from 7-ketocholesterol-induced apoptotic cell death
[64].</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="increases">
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="SCHEM">7-Ketocholesterol</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">apoptosis</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="negativeCorrelation">
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="SCHEM">7-Ketocholesterol</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="CHEBI">antioxidant</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="decreases">
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="CHEBI">antioxidant</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:statement bel:relationship="increases">
                        <bel:subject>
                            <bel:term bel:function="abundance">
                                <bel:parameter bel:ns="SCHEM">7-Ketocholesterol</bel:parameter>
                            </bel:term>
                        </bel:subject>
                        <bel:object>
                            <bel:term bel:function="biologicalProcess">
                                <bel:parameter bel:ns="GO">apoptosis</bel:parameter>
                            </bel:term>
                        </bel:object>
                    </bel:statement>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:annotation bel:refID="Tissue">Muscle, Smooth, Vascular</bel:annotation>
                <bel:evidence>In addition, another oxygen-radical scavenger enzyme,
catalase, can prevent VSMC apoptosis triggered by hydrogen
peroxide [27,65].</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="increases">
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="CHEBI">hydrogen peroxide</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">apoptosis</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="decreases">
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">CAT</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:statement bel:relationship="increases">
                        <bel:subject>
                            <bel:term bel:function="abundance">
                                <bel:parameter bel:ns="CHEBI">hydrogen peroxide</bel:parameter>
                            </bel:term>
                        </bel:subject>
                        <bel:object>
                            <bel:term bel:function="biologicalProcess">
                                <bel:parameter bel:ns="GO">apoptosis</bel:parameter>
                            </bel:term>
                        </bel:object>
                    </bel:statement>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:evidence>The proto-oncogene c-myc can
promote cell death (probably mediated through p53) or
cell proliferation, depending on its expression level. It
functions as a nuclear phosphoprotein with particular
properties of a transcription factor [68,69]. In serumdeprived
cultures, cells overexpressing c-myc readily
undergo apoptosis. In addition, deregulation of c-myc
causes apoptosis of VSMCs deprived of growth factors or
treated with cytokines such as interferon-g [70].</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="increases">
                <bel:annotationGroup>
                    <bel:annotation bel:refID="Tissue">Muscle, Smooth, Vascular</bel:annotation>
                </bel:annotationGroup>
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">MYC</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">apoptosis</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="increases">
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">MYC</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">cell proliferation</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:evidence>Tissue factor (TF) is a 47 kDa transmembrane glycoprotein
that initiates blood coagulation by binding
coagulation factor VII and its activated form (factor
VIIa), to produce a high-affinity complex [72] that
proteolytically activates factors IX and X, leading to
thrombin generation.</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="peptidaseActivity">
                        <bel:term bel:function="complexAbundance">
                            <bel:term bel:function="proteinAbundance">
                                <bel:parameter bel:ns="HGNC">F3</bel:parameter>
                            </bel:term>
                            <bel:term bel:function="proteinAbundance">
                                <bel:parameter bel:ns="HGNC">F7</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="peptidaseActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">F9</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="peptidaseActivity">
                        <bel:term bel:function="complexAbundance">
                            <bel:term bel:function="proteinAbundance">
                                <bel:parameter bel:ns="HGNC">F3</bel:parameter>
                            </bel:term>
                            <bel:term bel:function="proteinAbundance">
                                <bel:parameter bel:ns="HGNC">F7</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="peptidaseActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">F10</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="increases">
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="peptidaseActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">F9</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="peptidaseActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">F2</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="increases">
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="peptidaseActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">F10</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="peptidaseActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">F2</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:annotation bel:refID="CellStructure">Cell Membrane</bel:annotation>
                <bel:evidence>TF works at the surface of cell
membranes, and its activity is highly dependent on the
presence of phosphatidylserine (PS), an anionic phospholipid
that is redistributed on the cell surface during
apoptotic death and confers a potent pro-coagulant activity
to the apoptotic cell [74].</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="increases">
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="CHEBI">phosphatidyl-L-serine</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="peptidaseActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">F3</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="increases">
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">apoptosis</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="CHEBI">phosphatidyl-L-serine</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="increases">
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="CHEBI">phosphatidyl-L-serine</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">coagulation</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:evidence>TIMP-3 can be anti-angiogenic by direct binding to vascular
endothelial growth factor (VEGF) receptor 2 in a matrix-metalloproteinase-
independent manner [94].</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="decreases">
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">TIMP3</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">angiogenesis</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="decreases">
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="complexAbundance">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">TIMP3</bel:parameter>
                        </bel:term>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">KDR</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">angiogenesis</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
    </bel:statementGroup>
    <bel:statementGroup>
        <bel:name>Pubmed 16962653</bel:name>
        <bel:comment>SIN1/MIP1 = MAPKAP1</bel:comment>
        <bel:annotationGroup>
            <bel:citation bel:type="PubMed">
                <bel:reference>16962653</bel:reference>
                <bel:name>Cell</bel:name>
                <bel:date>2006-10-07-04:00</bel:date>
                <bel:authorGroup>
                    <bel:author>Jacinto E</bel:author>
                    <bel:author>Facchinetti V</bel:author>
                    <bel:author>Liu D</bel:author>
                    <bel:author>Soto N</bel:author>
                    <bel:author>Wei S</bel:author>
                    <bel:author>Jung SY</bel:author>
                    <bel:author>Huang Q</bel:author>
                    <bel:author>Qin J</bel:author>
                    <bel:author>Su B</bel:author>
                </bel:authorGroup>
            </bel:citation>
        </bel:annotationGroup>
        <bel:statementGroup>
            <bel:name>Abstract 1</bel:name>
            <bel:annotationGroup>
                <bel:annotation bel:refID="Species">9606</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Abstract</bel:annotation>
                <bel:evidence>Phosphorylation at Ser473, along with Thr308 of its activation loop, is deemed necessary for Akt function, although the regulatory mechanisms and physiological importance of each phosphorylation site remain to be fully understood.</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">AKT1</bel:parameter>
                        <bel:term bel:function="proteinModification">
                            <bel:parameter>P</bel:parameter>
                            <bel:parameter>T</bel:parameter>
                            <bel:parameter>308</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="kinaseActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">AKT1</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">AKT1</bel:parameter>
                        <bel:term bel:function="proteinModification">
                            <bel:parameter>P</bel:parameter>
                            <bel:parameter>S</bel:parameter>
                            <bel:parameter>473</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="kinaseActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">AKT1</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:name>Abstract 2</bel:name>
            <bel:annotationGroup>
                <bel:annotation bel:refID="Species">9606</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Abstract</bel:annotation>
                <bel:evidence>Genetic ablation of sin1 abolished Akt-Ser473 phosphorylation and disrupted rictor-mTOR interaction but maintained Thr308 phosphorylation.</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="increases">
                <bel:comment>sin1 = MAPKAP1</bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">MAPKAP1</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">AKT1</bel:parameter>
                        <bel:term bel:function="proteinModification">
                            <bel:parameter>P</bel:parameter>
                            <bel:parameter>S</bel:parameter>
                            <bel:parameter>473</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:name>Results</bel:name>
            <bel:annotationGroup>
                <bel:annotation bel:refID="TextLocation">Results</bel:annotation>
                <bel:annotation bel:refID="Species">10090</bel:annotation>
            </bel:annotationGroup>
            <bel:statementGroup>
                <bel:name>Unnamed [2.3.1]</bel:name>
                <bel:annotationGroup>
                    <bel:annotation bel:refID="Cell">Fibroblasts</bel:annotation>
                    <bel:evidence>We next examined the Akt T-loop Thr308 phosphorylation
in wild-type and SIN1-/- cells. We found that although
Ser473 phosphorylation was completely abolished in the
SIN1-/- cells, Thr308 phosphorylation of Akt was not
blocked (Figure 3A).</bel:evidence>
                </bel:annotationGroup>
                <bel:statement bel:relationship="increases">
                    <bel:comment></bel:comment>
                    <bel:annotationGroup />
                    <bel:subject>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="MGI">Mapkap1</bel:parameter>
                        </bel:term>
                    </bel:subject>
                    <bel:object>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="MGI">Akt1</bel:parameter>
                            <bel:term bel:function="proteinModification">
                                <bel:parameter>P</bel:parameter>
                                <bel:parameter>S</bel:parameter>
                                <bel:parameter>473</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:object>
                </bel:statement>
                <bel:statement bel:relationship="causesNoChange">
                    <bel:annotationGroup />
                    <bel:subject>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="MGI">Mapkap1</bel:parameter>
                        </bel:term>
                    </bel:subject>
                    <bel:object>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="MGI">Akt1</bel:parameter>
                            <bel:term bel:function="proteinModification">
                                <bel:parameter>P</bel:parameter>
                                <bel:parameter>S</bel:parameter>
                                <bel:parameter>308</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:object>
                </bel:statement>
            </bel:statementGroup>
            <bel:statementGroup>
                <bel:annotationGroup>
                    <bel:annotation bel:refID="Cell">Fibroblasts</bel:annotation>
                    <bel:evidence>We also examined phosphorylation of TSC2, another
Akt target (Manning et al., 2002), at the Akt target sites
Ser939 and Thr1462 and found no significant difference
between wild-type and SIN1-/- cells upon serum and
insulin stimulation (Figure 3C).</bel:evidence>
                </bel:annotationGroup>
                <bel:statement bel:relationship="directlyIncreases">
                    <bel:comment></bel:comment>
                    <bel:annotationGroup />
                    <bel:subject>
                        <bel:term bel:function="kinaseActivity">
                            <bel:term bel:function="proteinAbundance">
                                <bel:parameter bel:ns="MGI">Akt1</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:subject>
                    <bel:object>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="MGI">Tsc2</bel:parameter>
                            <bel:term bel:function="proteinModification">
                                <bel:parameter>P</bel:parameter>
                                <bel:parameter>S</bel:parameter>
                                <bel:parameter>939</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:object>
                </bel:statement>
                <bel:statement bel:relationship="directlyIncreases">
                    <bel:comment>Human T1462 = Mouse T1465</bel:comment>
                    <bel:annotationGroup />
                    <bel:subject>
                        <bel:term bel:function="kinaseActivity">
                            <bel:term bel:function="proteinAbundance">
                                <bel:parameter bel:ns="MGI">Akt1</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:subject>
                    <bel:object>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="MGI">Tsc2</bel:parameter>
                            <bel:term bel:function="proteinModification">
                                <bel:parameter>P</bel:parameter>
                                <bel:parameter>T</bel:parameter>
                                <bel:parameter>1462</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:object>
                </bel:statement>
            </bel:statementGroup>
            <bel:statementGroup>
                <bel:annotationGroup>
                    <bel:annotation bel:refID="Cell">Fibroblasts</bel:annotation>
                    <bel:evidence>To identify a function that could be linked specifically to
Akt-Ser473 phosphorylation, we further examined known
Akt substrates that may have defective phosphorylation in
SIN1-/- cells. We found that phosphorylation of FoxO1/3a
(also called FKHR/FKHRL1) (Greer and Brunet, 2005), was
affected in SIN1-/- cells. In particular, phosphorylation of
FoxO1/3a at Thr24/Thr32 was significantly decreased in
the absence of SIN1 under normal growing and restimulated
conditions (Figure 4A).</bel:evidence>
                </bel:annotationGroup>
                <bel:statement bel:relationship="increases">
                    <bel:comment></bel:comment>
                    <bel:annotationGroup />
                    <bel:subject>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="MGI">Mapkap1</bel:parameter>
                        </bel:term>
                    </bel:subject>
                    <bel:object>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="MGI">Foxo1</bel:parameter>
                            <bel:term bel:function="proteinModification">
                                <bel:parameter>P</bel:parameter>
                                <bel:parameter>T</bel:parameter>
                                <bel:parameter>24</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:object>
                </bel:statement>
                <bel:statement bel:relationship="increases">
                    <bel:comment></bel:comment>
                    <bel:annotationGroup />
                    <bel:subject>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="MGI">Mapkap1</bel:parameter>
                        </bel:term>
                    </bel:subject>
                    <bel:object>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="MGI">Foxo3</bel:parameter>
                            <bel:term bel:function="proteinModification">
                                <bel:parameter>P</bel:parameter>
                                <bel:parameter>T</bel:parameter>
                                <bel:parameter>32</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:object>
                </bel:statement>
                <bel:statement bel:relationship="directlyIncreases">
                    <bel:comment></bel:comment>
                    <bel:annotationGroup />
                    <bel:subject>
                        <bel:term bel:function="kinaseActivity">
                            <bel:term bel:function="proteinAbundance">
                                <bel:parameter bel:ns="MGI">Akt1</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:subject>
                    <bel:object>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="MGI">Foxo1</bel:parameter>
                            <bel:term bel:function="proteinModification">
                                <bel:parameter>P</bel:parameter>
                                <bel:parameter>T</bel:parameter>
                                <bel:parameter>24</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:object>
                </bel:statement>
                <bel:statement bel:relationship="directlyIncreases">
                    <bel:comment></bel:comment>
                    <bel:annotationGroup />
                    <bel:subject>
                        <bel:term bel:function="kinaseActivity">
                            <bel:term bel:function="proteinAbundance">
                                <bel:parameter bel:ns="MGI">Akt1</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:subject>
                    <bel:object>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="MGI">Foxo3</bel:parameter>
                            <bel:term bel:function="proteinModification">
                                <bel:parameter>P</bel:parameter>
                                <bel:parameter>T</bel:parameter>
                                <bel:parameter>32</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:object>
                </bel:statement>
            </bel:statementGroup>
            <bel:statementGroup>
                <bel:annotationGroup>
                    <bel:annotation bel:refID="Cell">Fibroblasts</bel:annotation>
                    <bel:evidence>We also found that the recombinant FoxO1 could not be phosphorylated at
Thr24/32 in vitro by an Akt mutant harboring an alanine
mutation in either Thr308 or Ser473, whereas a Ser473
to Ala mutated Akt could still phosphorylate recombinant
GSK3 (Figure S2). These results indicate that Akt-Ser473
phosphorylation is required for FoxO1/3a phosphorylation
at Thr24/32.</bel:evidence>
                </bel:annotationGroup>
                <bel:statement bel:relationship="directlyIncreases">
                    <bel:comment></bel:comment>
                    <bel:annotationGroup />
                    <bel:subject>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="MGI">Akt1</bel:parameter>
                            <bel:term bel:function="proteinModification">
                                <bel:parameter>P</bel:parameter>
                                <bel:parameter>S</bel:parameter>
                                <bel:parameter>473</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:subject>
                    <bel:object>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="MGI">Foxo1</bel:parameter>
                            <bel:term bel:function="proteinModification">
                                <bel:parameter>P</bel:parameter>
                                <bel:parameter>T</bel:parameter>
                                <bel:parameter>24</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:object>
                </bel:statement>
                <bel:statement bel:relationship="directlyIncreases">
                    <bel:comment></bel:comment>
                    <bel:annotationGroup />
                    <bel:subject>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="MGI">Akt1</bel:parameter>
                            <bel:term bel:function="proteinModification">
                                <bel:parameter>P</bel:parameter>
                                <bel:parameter>S</bel:parameter>
                                <bel:parameter>473</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:subject>
                    <bel:object>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="MGI">Foxo3</bel:parameter>
                            <bel:term bel:function="proteinModification">
                                <bel:parameter>P</bel:parameter>
                                <bel:parameter>T</bel:parameter>
                                <bel:parameter>32</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:object>
                </bel:statement>
                <bel:statement bel:relationship="directlyIncreases">
                    <bel:annotationGroup />
                    <bel:subject>
                        <bel:term bel:function="kinaseActivity">
                            <bel:term bel:function="proteinAbundance">
                                <bel:parameter bel:ns="MGI">Akt1</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:subject>
                    <bel:object>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="MGI">Foxo1</bel:parameter>
                            <bel:term bel:function="proteinModification">
                                <bel:parameter>P</bel:parameter>
                                <bel:parameter>T</bel:parameter>
                                <bel:parameter>24</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:object>
                </bel:statement>
                <bel:statement bel:relationship="directlyIncreases">
                    <bel:annotationGroup />
                    <bel:subject>
                        <bel:term bel:function="kinaseActivity">
                            <bel:term bel:function="proteinAbundance">
                                <bel:parameter bel:ns="MGI">Akt1</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:subject>
                    <bel:object>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="MGI">Foxo3</bel:parameter>
                            <bel:term bel:function="proteinModification">
                                <bel:parameter>P</bel:parameter>
                                <bel:parameter>T</bel:parameter>
                                <bel:parameter>32</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:object>
                </bel:statement>
                <bel:statement bel:relationship="directlyIncreases">
                    <bel:annotationGroup />
                    <bel:subject>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="MGI">Akt1</bel:parameter>
                            <bel:term bel:function="proteinModification">
                                <bel:parameter>P</bel:parameter>
                                <bel:parameter>S</bel:parameter>
                                <bel:parameter>473</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:subject>
                    <bel:object>
                        <bel:term bel:function="kinaseActivity">
                            <bel:term bel:function="proteinAbundance">
                                <bel:parameter bel:ns="MGI">Akt1</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:object>
                </bel:statement>
            </bel:statementGroup>
            <bel:statementGroup>
                <bel:annotationGroup>
                    <bel:annotation bel:refID="Cell">Fibroblasts</bel:annotation>
                    <bel:evidence>In etoposide-
treated cells, there was a 2-fold increase in the
number of cells that underwent apoptosis after 48 hr in
SIN1 knockouts (Figure 4D). Thus, we find that the
SIN1-/- cells were more sensitive to stress-induced apoptosis,
suggesting that Akt-Ser473 phosphorylation plays
an important role in cell survival (Figures 4C and 4D).</bel:evidence>
                </bel:annotationGroup>
                <bel:statement bel:relationship="decreases">
                    <bel:comment></bel:comment>
                    <bel:annotationGroup />
                    <bel:subject>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="MGI">Mapkap1</bel:parameter>
                        </bel:term>
                    </bel:subject>
                    <bel:object>
                        <bel:term bel:function="biologicalProcess">
                            <bel:parameter bel:ns="GO">apoptosis</bel:parameter>
                        </bel:term>
                    </bel:object>
                </bel:statement>
            </bel:statementGroup>
            <bel:statementGroup>
                <bel:comment>For mouse Thr389 = Thr412. Thr389 is based on a human and rat isotypes that are not canonical SwissProt sequences.</bel:comment>
                <bel:annotationGroup>
                    <bel:evidence>The phosphorylation of S6K at Thr389,
which is the TORC1-mediated site, was not inhibited in
the SIN1-/- cells (Figure 5A).</bel:evidence>
                </bel:annotationGroup>
                <bel:statement bel:relationship="directlyIncreases">
                    <bel:comment></bel:comment>
                    <bel:annotationGroup />
                    <bel:subject>
                        <bel:term bel:function="kinaseActivity">
                            <bel:term bel:function="complexAbundance">
                                <bel:parameter bel:ns="NCM">TORC1 Complex</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:subject>
                    <bel:object>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="MGI">Rps6kb1</bel:parameter>
                            <bel:term bel:function="proteinModification">
                                <bel:parameter>P</bel:parameter>
                                <bel:parameter>T</bel:parameter>
                                <bel:parameter>412</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:object>
                </bel:statement>
            </bel:statementGroup>
            <bel:statementGroup>
                <bel:annotationGroup>
                    <bel:evidence>Likewise, phosphorylation of another translational regulator, 4EBP1, at the mTOR target site Thr37/46 (Gingras et al.,1999), was also not impaired in SIN1-/- cells (Figure 5A).</bel:evidence>
                </bel:annotationGroup>
                <bel:statement bel:relationship="directlyIncreases">
                    <bel:comment></bel:comment>
                    <bel:annotationGroup />
                    <bel:subject>
                        <bel:term bel:function="kinaseActivity">
                            <bel:term bel:function="complexAbundance">
                                <bel:parameter bel:ns="NCM">TORC2 Complex</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:subject>
                    <bel:object>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="MGI">Eif4ebp1</bel:parameter>
                            <bel:term bel:function="proteinModification">
                                <bel:parameter>P</bel:parameter>
                                <bel:parameter>T</bel:parameter>
                                <bel:parameter>36</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:object>
                </bel:statement>
                <bel:statement bel:relationship="directlyIncreases">
                    <bel:comment></bel:comment>
                    <bel:annotationGroup />
                    <bel:subject>
                        <bel:term bel:function="kinaseActivity">
                            <bel:term bel:function="complexAbundance">
                                <bel:parameter bel:ns="NCM">TORC2 Complex</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:subject>
                    <bel:object>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="MGI">Eif4ebp1</bel:parameter>
                            <bel:term bel:function="proteinModification">
                                <bel:parameter>P</bel:parameter>
                                <bel:parameter>T</bel:parameter>
                                <bel:parameter>45</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:object>
                </bel:statement>
                <bel:statement bel:relationship="directlyIncreases">
                    <bel:annotationGroup />
                    <bel:subject>
                        <bel:term bel:function="kinaseActivity">
                            <bel:term bel:function="proteinAbundance">
                                <bel:parameter bel:ns="MGI">Mtor</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:subject>
                    <bel:object>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="MGI">Eif4ebp1</bel:parameter>
                            <bel:term bel:function="proteinModification">
                                <bel:parameter>P</bel:parameter>
                                <bel:parameter>T</bel:parameter>
                                <bel:parameter>36</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:object>
                </bel:statement>
                <bel:statement bel:relationship="directlyIncreases">
                    <bel:annotationGroup />
                    <bel:subject>
                        <bel:term bel:function="kinaseActivity">
                            <bel:term bel:function="proteinAbundance">
                                <bel:parameter bel:ns="MGI">Mtor</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:subject>
                    <bel:object>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="MGI">Eif4ebp1</bel:parameter>
                            <bel:term bel:function="proteinModification">
                                <bel:parameter>P</bel:parameter>
                                <bel:parameter>T</bel:parameter>
                                <bel:parameter>45</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:object>
                </bel:statement>
            </bel:statementGroup>
            <bel:statementGroup>
                <bel:annotationGroup>
                    <bel:annotation bel:refID="Cell">Fibroblasts</bel:annotation>
                    <bel:evidence>Akt Ser473 was strongly induced in wild-type cells by different
growth factors such as the platelet-derived growth
factor, epidermal growth factor, and insulin, even in the
absence of amino acids and glucose (Figure 5B). In
SIN1-/- cells, Akt-Ser473 phosphorylation was not induced
by any type of stimulus.</bel:evidence>
                </bel:annotationGroup>
                <bel:statement bel:relationship="increases">
                    <bel:comment></bel:comment>
                    <bel:annotationGroup />
                    <bel:subject>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="MGI">Mapkap1</bel:parameter>
                        </bel:term>
                    </bel:subject>
                    <bel:object>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="MGI">Akt1</bel:parameter>
                            <bel:term bel:function="proteinModification">
                                <bel:parameter>P</bel:parameter>
                                <bel:parameter>S</bel:parameter>
                                <bel:parameter>473</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:object>
                </bel:statement>
                <bel:statement bel:relationship="increases">
                    <bel:comment></bel:comment>
                    <bel:annotationGroup />
                    <bel:subject>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="PFM">Pdgf Family</bel:parameter>
                        </bel:term>
                    </bel:subject>
                    <bel:object>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="MGI">Akt1</bel:parameter>
                            <bel:term bel:function="proteinModification">
                                <bel:parameter>P</bel:parameter>
                                <bel:parameter>S</bel:parameter>
                                <bel:parameter>473</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:object>
                </bel:statement>
                <bel:statement bel:relationship="increases">
                    <bel:comment></bel:comment>
                    <bel:annotationGroup />
                    <bel:subject>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="MGI">Egf</bel:parameter>
                        </bel:term>
                    </bel:subject>
                    <bel:object>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="MGI">Akt1</bel:parameter>
                            <bel:term bel:function="proteinModification">
                                <bel:parameter>P</bel:parameter>
                                <bel:parameter>S</bel:parameter>
                                <bel:parameter>473</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:object>
                </bel:statement>
                <bel:statement bel:relationship="increases">
                    <bel:comment></bel:comment>
                    <bel:annotationGroup />
                    <bel:subject>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="PFM">Ins Family</bel:parameter>
                        </bel:term>
                    </bel:subject>
                    <bel:object>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="MGI">Akt1</bel:parameter>
                            <bel:term bel:function="proteinModification">
                                <bel:parameter>P</bel:parameter>
                                <bel:parameter>S</bel:parameter>
                                <bel:parameter>473</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:object>
                </bel:statement>
            </bel:statementGroup>
            <bel:statementGroup>
                <bel:annotationGroup>
                    <bel:evidence>As shown
in Figures 5E and 5F, SIN1 was able to associate with Akt
under normal growth, starvation, or restimulated conditions.
Although SIN1 and Akt interacted under starved
condition, the SIN1 bound Akt was not phosphorylated
on Ser473 (Figure 5E).</bel:evidence>
                </bel:annotationGroup>
                <bel:statement>
                    <bel:comment></bel:comment>
                    <bel:annotationGroup />
                    <bel:subject>
                        <bel:term bel:function="complexAbundance">
                            <bel:term bel:function="proteinAbundance">
                                <bel:parameter bel:ns="MGI">Akt1</bel:parameter>
                            </bel:term>
                            <bel:term bel:function="proteinAbundance">
                                <bel:parameter bel:ns="MGI">Mapkap1</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:subject>
                </bel:statement>
            </bel:statementGroup>
            <bel:statementGroup>
                <bel:annotationGroup>
                    <bel:evidence>Akt has been well characterized as a prosurvival molecule,
and part of this function is mediated through its suppression
of the activity of the FoxO proteins (Greer and Brunet,
2005).</bel:evidence>
                </bel:annotationGroup>
                <bel:statement bel:relationship="directlyDecreases">
                    <bel:comment></bel:comment>
                    <bel:annotationGroup />
                    <bel:subject>
                        <bel:term bel:function="kinaseActivity">
                            <bel:term bel:function="proteinAbundance">
                                <bel:parameter bel:ns="MGI">Akt1</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:subject>
                    <bel:object>
                        <bel:term bel:function="transcriptionalActivity">
                            <bel:term bel:function="proteinAbundance">
                                <bel:parameter bel:ns="PFM">Foxo Family</bel:parameter>
                            </bel:term>
                        </bel:term>
                    </bel:object>
                </bel:statement>
            </bel:statementGroup>
        </bel:statementGroup>
    </bel:statementGroup>
    <bel:statementGroup>
        <bel:name>Pubmed 15350900</bel:name>
        <bel:annotationGroup>
            <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
            <bel:citation bel:type="PubMed">
                <bel:reference>15350900</bel:reference>
                <bel:name>Trends in molecular medicine</bel:name>
                <bel:authorGroup>
                    <bel:author>Barry RE</bel:author>
                    <bel:author>Krek W</bel:author>
                </bel:authorGroup>
            </bel:citation>
        </bel:annotationGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:annotation bel:refID="Species">9606</bel:annotation>
                <bel:evidence>For example, the inactivation
of VHL has been demonstrated in 70–80% of all
sporadic clear cell RCC, the major form of RCC, which
accounts for w2% of all cancer deaths worldwide [8].</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="negativeCorrelation">
                <bel:comment>curating to protein, since inactivation of gene may be via mutation, deletion, or hypermethylation and will affect protein levels</bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">VHL</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="pathology">
                        <bel:parameter bel:ns="MESHD">Carcinoma, Renal Cell</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:evidence>The best-established function of pVHL to date has been
as a substrate recognition component of an E3 ubiquitinprotein
ligase complex, comprising pVHL, Elongin C,
Elongin B, Cullin 2 and the RING finger protein, Rbx1,
and this is referred to as the VCB–Cul2 complex [17].</bel:evidence>
            </bel:annotationGroup>
            <bel:statement>
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="complexAbundance">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">VHL</bel:parameter>
                        </bel:term>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">TCEB1</bel:parameter>
                        </bel:term>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">TCEB2</bel:parameter>
                        </bel:term>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">CUL2</bel:parameter>
                        </bel:term>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">RBX1</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:comment>alpha subunits of HIF include HIF1A, EPAS1, and HIF3A</bel:comment>
            <bel:annotationGroup>
                <bel:evidence>In
this setting, pVHL targets the a-subunits of hypoxiainducible
factor (HIF) for ubiquitin-mediated proteolysis
under normal oxygen conditions [18].</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="molecularActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">VHL</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="degradation">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="molecularActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">VHL</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="degradation">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">EPAS1</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="molecularActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">VHL</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="degradation">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">HIF3A</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:evidence>The stabilization of HIF in response to hypoxia
involves the inactivation of prolylhydroxylases that
modify HIF at specific proline residues in an oxygendependent
manner. Proline hydroxylation marks HIF for
degradation by the VCB–Cul2 E3 ligase complex (Figure 3
and Box 1).</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="increases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="CHEBI">dioxygen</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        <bel:term bel:function="proteinModification">
                            <bel:parameter>H</bel:parameter>
                            <bel:parameter>P</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        <bel:term bel:function="proteinModification">
                            <bel:parameter>H</bel:parameter>
                            <bel:parameter>P</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="degradation">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        <bel:term bel:function="proteinModification">
                            <bel:parameter>P</bel:parameter>
                            <bel:parameter>H</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:statement bel:relationship="directlyIncreases">
                        <bel:subject>
                            <bel:term bel:function="catalyticActivity">
                                <bel:term bel:function="complexAbundance">
                                    <bel:term bel:function="proteinAbundance">
                                        <bel:parameter bel:ns="HGNC">VHL</bel:parameter>
                                    </bel:term>
                                    <bel:term bel:function="proteinAbundance">
                                        <bel:parameter bel:ns="HGNC">TCEB1</bel:parameter>
                                    </bel:term>
                                    <bel:term bel:function="proteinAbundance">
                                        <bel:parameter bel:ns="HGNC">TCEB2</bel:parameter>
                                    </bel:term>
                                    <bel:term bel:function="proteinAbundance">
                                        <bel:parameter bel:ns="HGNC">RBX1</bel:parameter>
                                    </bel:term>
                                    <bel:term bel:function="proteinAbundance">
                                        <bel:parameter bel:ns="HGNC">CUL2</bel:parameter>
                                    </bel:term>
                                </bel:term>
                            </bel:term>
                        </bel:subject>
                        <bel:object>
                            <bel:term bel:function="degradation">
                                <bel:term bel:function="proteinAbundance">
                                    <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                                </bel:term>
                            </bel:term>
                        </bel:object>
                    </bel:statement>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:evidence>The VHL-mediated proteolytic degradation of HIF
suppresses a transcription programme that is normally
engaged by HIF as part of the adaptive response of the cell
to hypoxia, such as the activation of vascular endothelial
growth factor (VEGF), which is a potent angiogenic factor
that is involved in the formation and differentiation of
blood vessels.</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="increases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="transcriptionalActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="rnaAbundance">
                        <bel:parameter bel:ns="HGNC">VEGFA</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="increases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">response to hypoxia</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="rnaAbundance">
                        <bel:parameter bel:ns="HGNC">VEGFA</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="increases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">VEGFA</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">angiogenesis</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:annotation bel:refID="TextLocation">Legend</bel:annotation>
                <bel:evidence>Transcriptional control is also maintained by a specific acetylation
(Ac) event at lysine 532 and an additional asparagine hydroxylation (OH) event at
position 863, both of which act as negative regulators of the transcriptional activity
of HIF.</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="directlyDecreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        <bel:term bel:function="proteinModification">
                            <bel:parameter>A</bel:parameter>
                            <bel:parameter>K</bel:parameter>
                            <bel:parameter>532</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="transcriptionalActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyDecreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        <bel:term bel:function="proteinModification">
                            <bel:parameter>H</bel:parameter>
                            <bel:parameter>N</bel:parameter>
                            <bel:parameter>863</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="transcriptionalActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">Neoplasms</bel:annotation>
                <bel:evidence>highly vascular phenotype of
VHL-null tumours.</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="negativeCorrelation">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">VHL</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">vasculogenesis</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">Carcinoma, Renal Cell</bel:annotation>
                <bel:evidence>The inhibition of HIF-2a expression by
siRNA inhibits the growth of VHL-negative tumours [20].
Furthermore, the re-introduction of a degradation-resistant
mutant of HIF-2a into RCC cells ectopically expressing
pVHL abolishes the ability of VHL to suppress the
growth of these cell lines [21].</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="increases">
                <bel:comment>HIF2-alpha = EPAS1</bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">EPAS1</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">cell growth</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:annotation bel:refID="TextLocation">Legend</bel:annotation>
                <bel:evidence>Hydroxylation at two proline residues on the HIF polypeptide mediates
interactions between the b-domain of the von Hippel–Lindau protein
(pVHL) and HIF [60]. Each site can interact independently with pVHL,
potentially contributing to the extremely rapid proteolysis of HIF-a that
is observed under normoxic conditions. These sites contain a
conserved LxxLAP motif and are targeted by proline hydroxylases
(PHD) that, in mammalian cells, are provided by three isoforms
termed PHD 1–3 [61].</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        <bel:term bel:function="proteinModification">
                            <bel:parameter>H</bel:parameter>
                            <bel:parameter>P</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="complexAbundance">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">VHL</bel:parameter>
                        </bel:term>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment>PHD1-3 = EGLN1 -3</bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="catalyticActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">EGLN1</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        <bel:term bel:function="proteinModification">
                            <bel:parameter>H</bel:parameter>
                            <bel:parameter>P</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="catalyticActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">EGLN2</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        <bel:term bel:function="proteinModification">
                            <bel:parameter>H</bel:parameter>
                            <bel:parameter>P</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="catalyticActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">EGLN3</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        <bel:term bel:function="proteinModification">
                            <bel:parameter>H</bel:parameter>
                            <bel:parameter>P</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="increases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="CHEBI">dioxygen</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="degradation">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:annotation bel:refID="TextLocation">Legend</bel:annotation>
                <bel:evidence>In a second hydroxylation-dependent control,
b-hydroxylation of an asparaginyl residue in the C-terminal activation
domain of HIF-a (N803 in human HIF-1a) is regulated by a HIF
asparaginyl hydroxylase called FIH (factor inhibiting HIF) [62,63].
Hydroxylation at this site prevents the binding of the transcriptional
co-activators p300/CBP (CREB binding protein). Under normoxic
conditions, these hydroxylation reactions provide a dual mechanism
for HIF inactivation that involves proteolytic destruction and the
inhibition of transcriptional activity [64].</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="directlyDecreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        <bel:term bel:function="proteinModification">
                            <bel:parameter>H</bel:parameter>
                            <bel:parameter>N</bel:parameter>
                            <bel:parameter>803</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="complexAbundance">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        </bel:term>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">CREBBP</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyDecreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        <bel:term bel:function="proteinModification">
                            <bel:parameter>H</bel:parameter>
                            <bel:parameter>N</bel:parameter>
                            <bel:parameter>803</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="complexAbundance">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        </bel:term>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">EP300</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment>FIH = HIF1AN</bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="catalyticActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">HIF1AN</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        <bel:term bel:function="proteinModification">
                            <bel:parameter>H</bel:parameter>
                            <bel:parameter>N</bel:parameter>
                            <bel:parameter>803</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="complexAbundance">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        </bel:term>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">CREBBP</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="transcriptionalActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="complexAbundance">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        </bel:term>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">EP300</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="transcriptionalActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:comment>These hydroxylases refers to PHD1-3 (EGLN1-3) and FIH (HIF1AN), mentioned earlier in the paragraph</bel:comment>
            <bel:annotationGroup>
                <bel:annotation bel:refID="TextLocation">Legend</bel:annotation>
                <bel:evidence>These hydroxylases are all
Fe(II)- and 2-oxoglutarate-dependent dioxygenases that require molecular
oxygen. Therefore, HIFa becomes stabilized under hypoxic
conditions in which oxygen availability is low.</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="CHEBI">dioxygen</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="catalyticActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">EGLN1</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="CHEBI">dioxygen</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="catalyticActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">EGLN2</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="CHEBI">dioxygen</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="catalyticActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">EGLN3</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment>FIH = HIF1AN</bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="CHEBI">dioxygen</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="catalyticActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">HIF1AN</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="CHEBI">iron(2+)</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="catalyticActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">EGLN1</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="CHEBI">iron(2+)</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="catalyticActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">EGLN2</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="CHEBI">iron(2+)</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="catalyticActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">EGLN3</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="CHEBI">iron(2+)</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="catalyticActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">HIF1AN</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="CHEBIID">16810</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="catalyticActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">EGLN1</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="CHEBIID">16810</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="catalyticActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">EGLN2</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="CHEBIID">16810</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="catalyticActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">EGLN3</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment>FIH = HIF1AN</bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="abundance">
                        <bel:parameter bel:ns="CHEBIID">16810</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="catalyticActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">HIF1AN</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="increases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">response to hypoxia</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:annotation bel:refID="TextLocation">Legend</bel:annotation>
                <bel:evidence>Furthermore, an
acetyltransferase, ARD1, acetylates K532, a residue previously
shown to result in HIFa stability, thereby negatively regulating it
[65]. Jab1, a transcriptional co-activator, has been shown to positively
regulate HIFa [66].</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment>AARD1 = NAA10</bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="catalyticActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">NAA10</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        <bel:term bel:function="proteinModification">
                            <bel:parameter>A</bel:parameter>
                            <bel:parameter>K</bel:parameter>
                            <bel:parameter>532</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="catalyticActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">NAA10</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="degradation">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        <bel:term bel:function="proteinModification">
                            <bel:parameter>A</bel:parameter>
                            <bel:parameter>K</bel:parameter>
                            <bel:parameter>532</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="degradation">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="increases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="transcriptionalActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">COPS5</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">Carcinoma, Renal Cell</bel:annotation>
                <bel:evidence>RCC cells
lacking functional pVHL overexpress various growth
factors, including platelet-derived growth factor b
(PDGFb), VEGF and transforming growth factor
(TGF)-a [25]. The latter is a bona fide renal-cell mitogen
that activates the Ras–Raf–MAP kinase signalling
cascade through its cognate epidermal growth factor
(EGF) cell-surface receptor [26].</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="negativeCorrelation">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">VHL</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">PDGFB</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="negativeCorrelation">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">VHL</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">VEGFA</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="negativeCorrelation">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">VHL</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">TGFA</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">TGFA</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="kinaseActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">EGFR</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="increases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">TGFA</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="gtpBoundActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="PFH">RAS Family</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="increases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="kinaseActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">EGFR</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="gtpBoundActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="PFH">RAS Family</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">Carcinoma, Renal Cell</bel:annotation>
                <bel:evidence>The overproduction of
TGF-a in RCC cells is, at least in part, HIF-dependent and
a major contributory event that confers a growth advantage
to these cells [25,27].</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="increases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="transcriptionalActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">TGFA</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="increases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">TGFA</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">cell growth</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:evidence>tumour necrosis factor (TNF)-a has been shown to
promote HIF-1a accumulation, and this might involve a
VHL-dependent step [33,34].</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="increases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">TNF</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">Carcinoma, Renal Cell</bel:annotation>
                <bel:evidence>In particular, it
has been reported that RCC cells can be sensitized to
TNF-a-induced cytotoxicity by re-introducing wild-type
VHL [38]. The authors highlight the fact that TNFreceptor
engagement by TNF-a triggers the activation of
atypical protein kinase C (aPKC), which, through IKKb
phosphorylation, liberates NFkB, thereby initiating the
transcription of genes that are involved in apoptosis</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="increases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">VHL</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:statement bel:relationship="increases">
                        <bel:subject>
                            <bel:term bel:function="proteinAbundance">
                                <bel:parameter bel:ns="HGNC">TNF</bel:parameter>
                            </bel:term>
                        </bel:subject>
                        <bel:object>
                            <bel:term bel:function="biologicalProcess">
                                <bel:parameter bel:ns="GO">cell death</bel:parameter>
                            </bel:term>
                        </bel:object>
                    </bel:statement>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="increases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="molecularActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">TNFRSF1A</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="kinaseActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="PFH">PRKC Family</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="kinaseActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="PFH">PRKC Family</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">IKBKB</bel:parameter>
                        <bel:term bel:function="proteinModification">
                            <bel:parameter>P</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">TNF</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="molecularActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">TNFRSF1A</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="increases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">IKBKB</bel:parameter>
                        <bel:term bel:function="proteinModification">
                            <bel:parameter>P</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="transcriptionalActivity">
                        <bel:term bel:function="complexAbundance">
                            <bel:parameter bel:ns="NCH">Nfkb Complex</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:evidence>pVHL
has been shown to bind directly to various aPKC isoforms
and to target aPKCl for ubiquitin-mediated degradation
[39,40].</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment>PKC lambda = PKC iota</bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">VHL</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="degradation">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">PRKCI</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">Neoplasms</bel:annotation>
                <bel:evidence>pVHL has also been implicated in tumour invasion and
metastasis, which represent complex multi-step processes
that require the proteolytic degradation of the basement
membrane and tissue matrix, changes in cell polarity and
motility, and the attachment and detachment of cells to
and from the extracellular matrix (ECM) [41].</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="association">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">VHL</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="pathology">
                        <bel:parameter bel:ns="MESHD">Neoplasm Invasiveness</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="association">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">VHL</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="pathology">
                        <bel:parameter bel:ns="MESHD">Neoplasm Metastasis</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:evidence>Nevertheless, the
restored ability of pVHL-positive transfectants to assemble
extracellular fibronectin was mediated by b1 integrins,
implying that pVHL controls ECM assembly, at least in
part, through integrin signalling [46]. A recent development
has demonstrated that an ubiquitin-like molecule,
NEDD8, covalently modifies pVHL and that a neddylation-
defective pVHL mutant, despite retaining its ability
to degrade HIF, fails to promote the assembly of a
fibronectin matrix [47].</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="increases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">VHL</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">extracellular matrix assembly</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="increases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">VHL</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:statement bel:relationship="increases">
                        <bel:subject>
                            <bel:term bel:function="biologicalProcess">
                                <bel:parameter bel:ns="GO">integrin-mediated signaling pathway</bel:parameter>
                            </bel:term>
                        </bel:subject>
                        <bel:object>
                            <bel:term bel:function="biologicalProcess">
                                <bel:parameter bel:ns="GO">extracellular matrix assembly</bel:parameter>
                            </bel:term>
                        </bel:object>
                    </bel:statement>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:evidence>The regulation of insulin growth factor (IGF)-I-mediated
cell invasion of RCC cells appears to be dependent upon
PKCd inhibition by pVHL. This inhibition is mediated
through a protein–protein interaction involving a domain
of pVHL that shows similarity to protein kinase inhibitor
(PKI), a natural inhibitor of cAMP-dependent protein
kinase (PKA) [48]</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="directlyDecreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">VHL</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="kinaseActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">PRKCD</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="increases">
                <bel:comment></bel:comment>
                <bel:annotationGroup>
                    <bel:annotation bel:refID="Disease">Carcinoma, Renal Cell</bel:annotation>
                </bel:annotationGroup>
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">IGF1</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="pathology">
                        <bel:parameter bel:ns="MESHD">Neoplasm Invasiveness</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:evidence>In contrast to protein-binding inhibition,
evidence has shown that pVHL binds to both
atypical PKC isoforms (l and z) through its b-domain, and
in the case of activated aPKCl, mediates its turnover as
part of the E3-ligase function of pVHL [39,40]. Although
the functional significance of this inhibition remains
elusive, given the central role for atypical PKCs
(especially aPKCz) in establishing cell polarity in conjunction
with PAR6 and the GTPase CDC42 [49], one
could envisage a scenario whereby the loss of pVHL leads
to altered cell polarity and, by extension, aberrant cell
migration.</bel:evidence>
            </bel:annotationGroup>
            <bel:statement>
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="complexAbundance">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">VHL</bel:parameter>
                        </bel:term>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">PRKCZ</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
            </bel:statement>
            <bel:statement>
                <bel:comment>PKC lambda = PKC iota (PRKCI)</bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="complexAbundance">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">VHL</bel:parameter>
                        </bel:term>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">PRKCI</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
            </bel:statement>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="catalyticActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">VHL</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="degradation">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">PRKCI</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="increases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="kinaseActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">PRKCZ</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">establishment of cell polarity</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:evidence>Consistent with this, pVHL30 has been shown to
co-localize with the microtubule network in vivo and to
promote microtubule stabilization [12]. Because microtubule
dynamics have been intimately linked to the
process of directed cell migration [49],</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="increases">
                <bel:comment>&quot;microtubule stabilization&quot; synonym = &quot;negative regulation of microtubule depolymerization&quot;</bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">VHL</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">negative regulation of microtubule depolymerization</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:evidence>This same study
demonstrated that the loss of VHL function negatively
regulates tissue inhibitor of metalloproteinase 2 (TIMP-2),
resulting in the upregulation of matrix metalloproteinase
2 (MMP2) and MMP9, thereby implicating pVHL in the
control of these molecules.</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="increases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">VHL</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="peptidaseActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">TIMP2</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="decreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="peptidaseActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">TIMP2</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">MMP2</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="decreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="peptidaseActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">TIMP2</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">MMP9</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:evidence>Importantly, it has been demonstrated that hypoxia
promotes tumour cell invasion by inducing the expression
of the Met receptor [54]. This establishes a mechanism
whereby transformed cells can be spurred to exit a hypoxic
microenvironment and invade the surrounding tissues,
which provide more favourable growth conditions.
Because HIF-1a is involved in Met gene expression, the
constitutive activation of HIF-1a as a consequence of
pVHL deregulation provides a mechanism explaining the
observation that the expression of HGF and Met receptor
is associated with genetic alterations of VHL in primary
RCC.</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="increases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">response to hypoxia</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="rnaAbundance">
                        <bel:parameter bel:ns="HGNC">MET</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="increases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="transcriptionalActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="rnaAbundance">
                        <bel:parameter bel:ns="HGNC">MET</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="association">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="geneAbundance">
                        <bel:parameter bel:ns="HGNC">VHL</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="rnaAbundance">
                        <bel:parameter bel:ns="HGNC">MET</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="association">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="geneAbundance">
                        <bel:parameter bel:ns="HGNC">VHL</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="rnaAbundance">
                        <bel:parameter bel:ns="HGNC">HGF</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">Carcinoma, Renal Cell</bel:annotation>
                <bel:evidence>The gene encoding the chemokine receptor CXCR4 has
been discovered as a novel HIF target based on a
microarray comparison of genetic profiles derived from
VHL-null RCC cells and their isogenic wild-type VHLexpressing
counterparts [52].</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="decreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">VHL</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="rnaAbundance">
                        <bel:parameter bel:ns="HGNC">CXCR4</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:evidence>The fact that CXCR4 is a hypoxia-inducible gene
provided a potential mechanistic explanation for CXCR4
upregulation during tumour cell evolution. CXCR4-
induced cell-surface expression due to the loss of VHL
function confers enhanced migratory potential to RCC
cells in response to its cognate ligand stromal-derived
factor 1 (SDF1).</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="increases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">response to hypoxia</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="rnaAbundance">
                        <bel:parameter bel:ns="HGNC">CXCR4</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="decreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup>
                    <bel:annotation bel:refID="Disease">Carcinoma, Renal Cell</bel:annotation>
                </bel:annotationGroup>
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">VHL</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="cellSurfaceExpression">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">CXCR4</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="directlyIncreases">
                <bel:comment>SDF1 = CXCL12</bel:comment>
                <bel:annotationGroup>
                    <bel:annotation bel:refID="Disease">Carcinoma, Renal Cell</bel:annotation>
                </bel:annotationGroup>
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">CXCL12</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="molecularActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">CXCR4</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="increases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="molecularActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">CXCR4</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">cell migration</bel:parameter>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
        <bel:statementGroup>
            <bel:annotationGroup>
                <bel:annotation bel:refID="TextLocation">Legend</bel:annotation>
                <bel:evidence>Figure 4. The role of hypoxia-inducible factor (HIF) in conferring tumour growth
potential. In solid tumours, HIFa is stabilised under conditions of low oxygen due to
a lack of vascularisation and the subsequent evolution of a hypoxic microenvironment.
In a VHL-null tumour, HIFa is constitutively active, and can initiate genetic
programmes within the entire population of cells that would normally be activated
only under hypoxic conditions.</bel:evidence>
            </bel:annotationGroup>
            <bel:statement bel:relationship="decreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="biologicalProcess">
                        <bel:parameter bel:ns="GO">response to hypoxia</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="degradation">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
            <bel:statement bel:relationship="decreases">
                <bel:comment></bel:comment>
                <bel:annotationGroup />
                <bel:subject>
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">VHL</bel:parameter>
                    </bel:term>
                </bel:subject>
                <bel:object>
                    <bel:term bel:function="transcriptionalActivity">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">HIF1A</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:object>
            </bel:statement>
        </bel:statementGroup>
    </bel:statementGroup>
</bel:document>
